-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Enovis, Lowers Price Target to $47

Benzinga·09/02/2026 12:50:30
Listen to the news
Citizens analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from $55 to $47.